SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001214659-18-004795
Filing Date
2018-07-09
Accepted
2018-07-09 17:12:31
Documents
1

Document Format Files

Seq Description Document Type Size
1 l75180sc13g.htm SC 13G 50146
  Complete submission text file 0001214659-18-004795.txt   51929
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Subject) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-39976 | Film No.: 18945343
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3031 TISCH WAY SUITE 505 SAN JOSE CA 95128
Business Address 3031 TISCH WAY SUITE 505 SAN JOSE CA 95128 6503386447
Altamont Phamaceutical Holdings, LLC (Filed by) CIK: 0001745878 (see all company filings)

IRS No.: 812760468 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G